Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors
Abstract We have developed a high-throughput drug discovery platform, measuring fluorescence resonance energy transfer (FRET) with fluorescent alpha-synuclein (αSN) biosensors, to detect spontaneous pre-fibrillar oligomers in living cells. Our two αSN FRET biosensors provide complementary insight in...
Main Authors: | Anthony R. Braun, Elly E. Liao, Mian Horvath, Prakriti Kalra, Karen Acosta, Malaney C. Young, Noah Nathan Kochen, Chih Hung Lo, Roland Brown, Michael D. Evans, William C. K. Pomerantz, Elizabeth Rhoades, Kelvin Luk, Razvan L. Cornea, David D. Thomas, Jonathan N. Sachs |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-06-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-021-00195-6 |
Similar Items
-
Advancements in a FRET Biosensor for Live-Cell Fluorescence-Lifetime High-Throughput Screening of Alpha-Synuclein
by: Anthony R. Braun, et al.
Published: (2023-07-01) -
Alpha-Synuclein FRET Biosensors Reveal Early Alpha-Synuclein Aggregation in the Endoplasmic Reticulum
by: Fabiana Miraglia, et al.
Published: (2020-08-01) -
Molecular Mechanism of a FRET Biosensor for the Cardiac Ryanodine Receptor Pathologically Leaky State
by: Bengt Svensson, et al.
Published: (2023-08-01) -
Developments in FRET- and BRET-Based Biosensors
by: Yuexin Wu, et al.
Published: (2022-10-01) -
Resource for FRET-Based Biosensor Optimization
by: Heonsu Kim, et al.
Published: (2022-06-01)